Raymond James Financial’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$21.8M	Buy	822,278 +174,887	+27%	+$4.63M	0.01%	1309
2025 Q1	$15.6M	Buy	647,391 +28,922	+5%	+$698K	0.01%	1494
2024 Q4	$24.9M	Buy	+618,469	New	+$24.9M	0.01%	1156